The cardiovascular response to exercise has long been a focus of interest. Over a century
ago, the first descriptions of electrocardiographic changes occurring during exercise …

Brugada syndrome (BrS) is an inherited primary arrhythmia syndrome, first described in
1953 by Osher and Wolff, 1 and subsequently by several others including Martini and …

This commentary refers to 'Implantable loop recorders in patients with Brugada syndrome:
the BruLoop study', by M. Bergonti et al., https://doi. org/10.1093/eurheartj/ehae133 and the …

We have recently read with great interest the article by Dyrbus et al. titled 'Appropriate and
inappropriate therapies in remotely monitored patients with cardiac implantable devices …

Purpose of review The goal of this review is to assess recent literature regarding the risk of
sudden cardiac death (SCD) in athletes with Brugada syndrome (BrS) and critically evaluate …

We strongly appreciate the comment by Dendramis and Brugada 1 in the manuscript entitled
'Appropriate and inappropriate therapies in remotely monitored patients with Brugada …

Over the last three decades, what is referred to as Brugada syndrome (BrS) has developed
from a clinical observation of initially a few cases of sudden cardiac death (SCD) in the …

The article discusses the importance of not generalizing data on Brugada syndrome (BrS)
patients who have a low probability of major ventricular arrhythmic events. It states that an …

From a pathophysiological point of view, the review by the authors appears to be
illuminating for clinicians who are directly interested every day in managing these types of …

The subcutaneous implantable cardioverter-defibrillator (S-ICD) has emerged as a feasible
alternative to the transvenous ICD in the treatment of ventricular tachyarrhythmias in patients …